NDC 00074-5015-01
Philadelphia, PA
Price type
All methodologies
$9.2k
Case rate
Not reported
Fee schedule
$9.2k
Per diem
$474
Percent of billed charges
$22.6k
Other
$17
Last updated: Mar 31, 2026
See RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.